September 19, 2019
Lineage Cell Therapeutics Receives CE Mark Approval for Renevia
Lineage Cell Therapeutic’s comparative clinical trial met its primary endpoint of change in hemifacial volume at six months (p<.001), which…
Pharmaceuticals, Biotechnology and Life Sciences
Lineage Cell Therapeutic’s comparative clinical trial met its primary endpoint of change in hemifacial volume at six months (p<.001), which…